Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020
Current assets
Cash and cash equivalents	$ 55.5	$ 43.8
Accounts receivable, net	425.0	184.7
Contract assets	72.5	55.6
Inventory	17.4	9.9
Restricted cash	8.6	1.5
Assets held for sale	2.2	5,942.1
Other current assets	11.0	8.7
Total current assets	592.2	6,246.3
Investments	49.9	55.4
Deferred tax asset	2.8	3.0
Property, plant and equipment, net	168.2	112.8
Goodwill	122.8	111.0
Intangibles, net	213.1	172.1
Other assets	72.5	42.2
Total assets	1,221.5	6,742.8
Current liabilities
Accounts payable	183.2	69.7
Accrued liabilities	99.7	77.1
Current portion of debt obligations	71.1	433.6
Contract liabilities	161.4	52.2
Liabilities held for sale	0.0	5,306.7
Other current liabilities	18.0	12.9
Total current liabilities	533.4	5,952.2
Deferred tax liability	8.0	7.0
Debt obligations	602.8	127.9
Other liabilities	61.7	39.8
Total liabilities	1,205.9	6,126.9
Commitments and contingencies
Temporary equity
Preferred stock	19.1	10.4
Redeemable noncontrolling interest	51.2	5.3
Total temporary equity	70.3	15.7
Stockholders’ (deficit) equity
Common stock	0.1	0.1
Additional paid-in capital	331.2	355.7
Treasury stock, at cost: 1,389,216 and 1,109,751 shares at September 30, 2021 and December 31, 2020, respectively	(5.2)	(4.2)
Accumulated deficit	(411.5)	(188.7)
Accumulated other comprehensive income	3.2	396.9
Total INNOVATE Corp. stockholders’ (deficit) equity	(82.2)	559.8
Noncontrolling interest	27.5	40.4
Total stockholders’ (deficit) equity	(54.7)	600.2
Total liabilities, temporary equity and stockholders’ (deficit) equity	$ 1,221.5	$ 6,742.8